+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Asia Pacific Dilated Cardiomyopathy Market - Opportunities and Forecasts, 2017 - 2023

  • ID: 3773191
  • Report
  • September 2019
  • Region: Asia Pacific
  • Allied Analytics LLP
1 of 2

Enquire about COVID-19 updates for this product.

Enquire Now
Dilated cardiomyopathy (DCM) results from heart enlargement. It is a fetal cardiac disorder, where heart walls become weak and heart fails to pump blood efficiently. It could have negative impact on lungs, liver and other important organs due to improper supply of blood. Left ventricle is the major pumping chamber that can be initially affected in cardiomyopathy causing its enlargement. The other symptoms of cardiomyopathy include irregular heartbeats, blood clots and valve problems. Male individuals are more prone to cardiomyopathy than female individuals. The causes for dilated cardiomyopathy are genetic defects, infections, birth defects, certain cancer medications, drug and alcohol abuse and exposure to toxic metals. The available treatments focus to improve the blood flow of heart, which is the primary leads to cardiomyopathy.

The Asia-pacific market for dilated cardiomyopathy is segmented on the basis of treatment types and geography. The currently available treatment includes drugs and implantable devices. The different types of drugs used to treat dilated cardiomyopathy include angiotensin-converting enzyme (ACE) inhibitors, beta blockers, aldosterone antagonists, digitalis, angiotensin II receptor blockers and anticoagulants. Various therapy devices include implantable cardioverter-defibrillators (ICDs), biventricular pacemakers and heart pumps. Geographically, the Asia-pacific market for dilated cardiomyopathy is segmented into China, Japan, India, Indonesia, Singapore and others. India and China are promising market for the growth of dilated cardiomyopathy market due to the high prevalence of disease conditions such as cancer and cardiovascular diseases.

ZensunSci & tech, Aastrom Biosciences, Capricor Therapeutics, t2cure GmbH, Kasiak Research Pvt. Ltd. and MyoKardia are some of the key players operating in this market. Capricor Therapeutics, a California-based company, focused to develop the regenerative medicines and large molecule products for the treatment of heart diseases including dilated cardiomyopathy.

KEY BENEFITS

Pin-point analysis of geographic segments help to identify opportunities for growth within the dilated cardiomyopathy market
Porters Five Forces analysis examines the competitive structure of the dilated cardiomyopathy market and would assist market strategists in their respective decision making process
In-depth coverage of the dilated cardiomyopathy market including drivers, restraints and opportunities that would help professionals to better understand market behavior
Detailed study of the strategies of key leaders, partnerships and acquisitions in the dilated cardiomyopathy market would prove to be informative for professionals in corporate sector
The report provides a comprehensive analysis of the current market and estimations through 20142020, which would enable the stakeholders to capitalize on prevailing market opportunities
SWOT analysis enables to study the internal environment of the leading companies for strategy formulation

ASIA-PACIFIC DILATED CARDOMYOPATHY MARKET KEY SEGMENT

The Asia-pacific market for dilated cardiomyopathy is segmented into two broad categories such as treatment types and geography.

BY TREATMENT TYPES

Therapeutics

Angiotensin-converting enzyme (ACE) inhibitors
Beta blockers
Aldosterone antagonists
Digitalis
Angiotensin II receptor blockers
Anticoagulants

Therapy Devices (Implantable Devices)

Implantable cardioverter-defibrillators (ICDs)
Biventricular pacemakers
Heart pumps

MARKET BY GEOGRAPHY

China
Japan
India
Indonesia
Singapore
Other

Note: Product cover images may vary from those shown
2 of 2

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Adroll
adroll